Deutsche Bank
EW icon

Deutsche Bank’s Edwards Lifesciences EW Stock Holding History

Deutsche Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
+131,400
New +$10.8M ﹤0.01% 1035
2018
Q1 		– Sell
-750
Closed -$28K – 5461
2017
Q4 		$28K Buy
+750
New +$27.5K ﹤0.01% 4592

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deutsche Bank's EW Position: Q1 2026 in Review

Deutsche Bank increased its Edwards Lifesciences (EW) stake by 8.5% in Q1 2026, buying an estimated $39.3M and bringing the position to 6,055,023 shares worth $485M. The position accounts for 0.16% of the portfolio, ranked #136.

Deutsche Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $511M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Deutsche Bank held 6,055,023 shares of Edwards Lifesciences worth $485M as of Q1 2026.
  • Deutsche Bank bought 476,227 Edwards Lifesciences shares in Q1 2026, an estimated $39.3M.
  • Edwards Lifesciences made up 0.16% of Deutsche Bank's portfolio in Q1 2026, its #136 holding.
  • Deutsche Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Edwards Lifesciences position peaked at $511M in Q4 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.